Plus   Neg

Regeneron Pharmaceuticals Q1 adjusted earnings Beat Estimates

Regeneron Pharmaceuticals (REGN) reported earnings for its first quarter that increased from the same period last year.

The company's earnings came in at $624.6 million, or $5.43 per share. This compares with $461.1 million, or $3.99 per share, in last year's first quarter.

Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $770.6 million or $6.60 per share for the period.

Analysts had expected the company to earn $6.13 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 33.6% to $1.83 billion from $1.37 billion last year.

Regeneron Pharmaceuticals earnings at a glance:

-Earnings (Q1): $770.6 Mln. vs. $517.7 Mln. last year.
-EPS (Q1): $6.60 vs. $4.45 last year.
-Analysts Estimate: $6.13
-Revenue (Q1): $1.83 Bln vs. $1.37 Bln last year.

Full year revenue guidance: $1.900 - $2.040 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT